4%) as compared to surgery and foam sclerotherapy (78% and 77%) after 3 years
(Nijsten et al. 2009).
 Patients with varicosities, enlarged reticular veins, or telangiectasias in addition to saphenous refux benefit from simultaneous treatment with EVLA/RFA and ambulatory phlebectomy as opposed to staged treatment with improvement in early disease severity and
QoL scores (Aherne